title: Dobutamine stress Doppler echocardiography: reproducibility and physiologic left ventricular filling patterns.
abstract: Qualitatively, dobutamine stress echocardiography has become an established procedure. Quantitative results are in great demand but this is still difficult due to limited endo- and epicardial border definition. Transmitral Doppler variables are strictly quantitative and less subjective. Furthermore, ischemic alterations precede systolic ones (ischemic cascade). There are preliminary reports of the utility of dobutamine stress Doppler echocardiography, but proof of reproducibility and left ventricular filling patterns are still lacking. Fourteen healthy volunteers (10 men, 4 women, median age 25.9 years, range 21-32 years) were investigated according to the usual dobutamine stress echocardiographic protocol (5, 10, 15, 20, 30, 40 and 40 micrograms/kg/min + 0.5 mg atropine). At each titration step a standardized transmitral PW-Doppler recording with the sample volume positioned at the opened mitral leaflet tips was analyzed three times by two independent, experienced investigators. Of the early, late, and mean velocities (VmaxE, VmaxA, Vmean), time integrals (VTI-E, VTI-A, VTI), their ratios (E/A, E/A VTI), and various time intervals (Tacc, Tdec, E- and A-duration, FillT), VmaxE (0.82 to 1.09 m/s; P < 0.0001), VTI-E (16.17 to 17.19 cm; P < 0.0001) and Vmean (0.29 to 0.82 m/s; P < 0.0001) were found to have the greatest discriminatory power, commencing already at a dose of 10-15 micrograms/kg/min dobutamine. VmaxE and VTI-E demonstrated the smallest intra- and interobserver variation without any increase in variability during incremental dose titration. Assessment of the early diastolic filling pattern by Doppler echocardiography is a valuable quantitative and reproducible adjunct to conventional dobutamine stress echocardiography. Further controlled studies in coronary artery disease patients have to confirm, whether lower dobutamine doses could be used in the test and sensitivity increased due to better data acquisition in cases of limited echogenicity, less subjectivity, and earlier onset of ischemic alterations.
authors.affiliation: II. Medical Clinic, Johannes Gutenberg University, Mainz, Germany. nixdorff@2-med.klinik.uni-mainz.dc
authors.forename: U
authors.initials: U
authors.lastname: Nixdorff
authors.forename: S
authors.initials: S
authors.lastname: Wagner
authors.forename: R
authors.initials: R
authors.lastname: Erbel
authors.forename: S
authors.initials: S
authors.lastname: Mohr-Kahaly
authors.forename: P
authors.initials: P
authors.lastname: Weitzel
authors.forename: K
authors.initials: K
authors.lastname: Rieger
authors.forename: J
authors.initials: J
authors.lastname: Meyer
mesh_terms: D002316:Cardiotonic Agents; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology; D004280:Dobutamine; D015150:Echocardiography, Doppler / Q000187:drug effects; D005080:Exercise Test / Q000187:drug effects; D005260:Female; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000503:physiopathology; D015588:Observer Variation; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D016277:Ventricular Function, Left / Q000187:drug effects* / Q000502:physiology
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine